Any feedback?
Please rate this page
(search_result.php)
(0/150)

BRENDA support

Refine search

Search Crystallization (Commentary)

show results
Don't show organism specific information (fast!)
Search organism in taxonomic tree (slow, choose "exact" as search mode, e.g. "mammalia" for rat,human,monkey,...)
(Not possible to combine with the first option)
Refine your search

Search term:

Results 1 - 10 of 13 > >>
EC Number Crystallization (Commentary)
Show all pathways known for 2.2.1.6Display the word mapDisplay the reaction diagram Show all sequences 2.2.1.6-
Show all pathways known for 2.2.1.6Display the word mapDisplay the reaction diagram Show all sequences 2.2.1.6crystal structure analysis
Show all pathways known for 2.2.1.6Display the word mapDisplay the reaction diagram Show all sequences 2.2.1.6free enzyme and in complex with inhibitors, hanging drop vapor diffusion method, using 1 M sodium potassium tartrate, 0.1 M CHES and 0.1-0.2 M lithium sulfate
Show all pathways known for 2.2.1.6Display the word mapDisplay the reaction diagram Show all sequences 2.2.1.6homology modeling of enzyme based on the structure of the yeast enzyme.In the model, the S167 and S506 residues lie near the FAD binding site, while the S539 residue is found near the thiamine diphosphate binding site
Show all pathways known for 2.2.1.6Display the word mapDisplay the reaction diagram Show all sequences 2.2.1.6in complex with inhibitors N-[(4-methylpyrimidin-2-yl)carbamoyl]-2-nitrobenzenesulfonamide and methyl 2-([(4-methylpyrimidin-2-yl)carbamoyl]sulfamoyl)benzoate, to 3.0 A and 2.8 A resolution, respectively. In both complexes, the inhibitors are bound in the tunnel leading to the active site, such that the sole substituent of the heterocyclic ring is buried deepest and oriented towards the thiamine diphosphate. The cofactor is intact and present most likely as the hydroxylethyl intermediate
Show all pathways known for 2.2.1.6Display the word mapDisplay the reaction diagram Show all sequences 2.2.1.6in complex with penoxsulam, hanging drop vapor diffusion method, using 1.0 M succinic acid, pH 7.0, 0.1 M HEPES, pH 7.0, and 1% (w/v) PEG monomethyl ether 2000
Show all pathways known for 2.2.1.6Display the word mapDisplay the reaction diagram Show all sequences 2.2.1.6in complex with propoxycarbazone or thiencarbazone methyl, hanging drop vapor diffusion method, using 1.0 M Na/K tartrate, 0.1 M CHES, and 0.19 M (NH4)2SO4. In complex with bispyribac or pyrithiobac, hanging drop vapor diffusion method, using 20% (w/v) PEG 3350 and 0.2 M sodium citrate tribasic dihydrate or 0.2 M potassium citrate tribasic dihydrate
Show all pathways known for 2.2.1.6Display the word mapDisplay the reaction diagram Show all sequences 2.2.1.6in complex with pyruvate
Show all pathways known for 2.2.1.6Display the word mapDisplay the reaction diagram Show all sequences 2.2.1.6purified enzyme in the presence of thiamine diphosphate and Mg2+, and in a transition state with a 2-lactyl moiety bound to thiamine diphosphate, X-ray diffraction structure determination and analysis at 2.3 A resolution, molecular replacement
Show all pathways known for 2.2.1.6Display the word mapDisplay the reaction diagram Show all sequences 2.2.1.6purified recombinant wild-type and selenomethionine-labeled isozyme AHAS III in complex with valine, hanging drop vapour diffusion method, room temperature, 0.0036 ml of protein solution containing 10-25 mg/ml protein and 0.5 M MgCl2, is mixed with reservoir solution containing 30-40% PEG 400, 0.4-0.6 M MgCl2, 100 mM Tris-HCl, pH 8.5, tetragonal or orthorhombic crystals, X-ray diffraction structure determination and analysis at 1.75-2.5 A resolution
Results 1 - 10 of 13 > >>